Introduction to TPN 新光吳火獅紀念醫院 內科部 胃腸肝膽科 柯威旭 醫師 Nutrition Support Team • • • • • • • Physicians Clinical pharmacists Nurse-Clinicians Dietitians Laboratory research technician Ward nursing staff In SKH:主任,執行秘書,各科醫師,藥劑師,營養 師 Source of Nutrition • Enteral nutrition • Parenteral nutrition – Central parenteral nutrition (CPN=TPN) – Peripheral parenteral nutrition (PPN) – Long-term home parenteral nutrition (HPN) Clinical decision algorithm route of nutrition support Nutrition Assessment Decision to institute special nutrition support YES Functional GI Tract Enteral Nutrition Short-term: NG, ND,NJ Parenteral Nutrition Long-term: Gastrostomy Jejunostomy GI function Intact Nutrients Adequate NO PPN Defined Formula Inadequate PN Oral Feeding Adequate TPN GI function return YES NO PPN • • • • High risk of thrombophlebitis Osmolarity: less than 800-900 mOsm/kg Short-term: up to 2 weeks Not the optimal choice for – significant malnutrition – severe metabolic stress – large nutrient or electrolyte needs (especially potassium, a strong vascular irritant) – fluid restriction – the need for prolonged intravenous nutrition support Indications of TPN • Impossibility for enteral nutrition • Inadequacy for enteral nutrition • Increment of the severity of disease by enteral nutrition PLUS • Anticipated to have PN for more than 7 days TPN in Internal Medicine • Acute pancreatitis • Intestinal disease (IBD, NEC, radiation colitis, ileus, intractable diarrhea / vomiting) • Cancer • Hepatic failure • Renal failure • Short bowel syndrome • Enterocutaneous fistula • AIDS • Perioperative support TPN should not be used in • • • • Malignancy: poor response to R/T or C/T Active stage of IBD Relative preserved GI function Hypertriglyceridemia (TG > 400 md/dl) Components of TPN • Carbohydrate, Amino acid, Fat, Electrolyte, Water, Vitamin, Trace element • Standard solution – Dextrose, Amino acid – Electrolyte (Na, K, Cl, Mg, Ca, P) – Vitamin (A, B1, B2, Niacin, B6, Panthothenic acid, C, D, E, Zn, Cu, Mn, Cr) • Lipid emulsion Dextrose-content Solution • 1 g glucose = 3.4 Kcal • 1 g glucose = 5 mOsm/L Amino acid solution 7% A.A. 含 essential A.A. 較高, 適用於腎衰竭病患 含高濃度 branch chain A.A., 低濃度 8% A.A. aromatic A.A., 可使肝衰竭病患之HE改善 12% A.A. 成人 Standard Solution 之A.A. 來源 Lipid emulsions Volume Calorie 10% intralipid 20% intralipid 10% lipofundin 500 ml/B 250 ml/B 100 ml/B 550 Kcal/B 500 Kcal/B 110 Kcal/B TPN formula • B: standard solution • D: 8% A.A., high BCAA, low AAA; for hepatic disease • E: 35% Dextrose, 12% A.A.; for HD and water restriction • F: 29% Dextrose, 12% & 7% A.A.; for ARF with HD • G: 29% Dextrose, 7% A.A.; for ESRD TPN Order Vascular Access for TPN Care Complication Infection Subclavian vein Easy High Low Internal jugular vein Hard Low High Femoral vein Hard Low Highest Antecubital vein Easy Low High Mechanical complication • Insertion-of-catheter related: – pneumothorax, brachial plexus injury, subclavian and carotid artery puncture, hemothorax, thoracic duct injury and chylothorax, cardiac perforation, catheter malposition • Air embolism • Catheter fragment embolism Metabolic complication • Fluid overload / Dehydration from osmotic diuresis • Hypertriglyceridemia • Hypocalcemia • Hypomagnesemia • Hypophosphatemia • Hyperglycemia / Rebound hypoglycemia on sudden cessation of TPN • Hyperammonemia • Hyperchloremic metabolic acidosis • NKHS Infectious complication • Catheter-related sepsis: Staph. epidermidis and aureus; solution contamination • GNB for immunocompromise • Direct evidence: tip culture or blood culture • Indirect evidence: fever (up to 38C, 2 times, every 4 hours), chills, abrupt increase of blood sugar, hypotension, tachycardia, leukocytosis Hepatic complication • Biochemical: elevated serum aminotransferase and alkaline phosphatase • Histological: steatosis, steatohepatitis, cholestasis, fibrosis and cirrhosis • Usually benign and transient, but severe in TPN for > 16 weeks • Additive use of Choline, Glutamine and Carnitine may be helpful • If cholestasis is present, Cu and Mg should be deleted to prevent acculumation in liver and BG Biliary complication • Acalculous cholecystitis, GB sludge, cholelithiasis in TPN for > 3 weeks • Decrease of bile salt reabsorption leads to formation of GB stone; • Encouraging enteral intake to stimulate GB contraction Intestinal complication • Villous atrophy: decreases in gut weight and mucosal height Metabolic bone disease • Present in TPN for > 3 months • Bone pain, bone fracture or asymptomatic but demineralization in CxR • Possible mechanisms – Aluminum toxicity – Vitamin D toxicity – Negative calcium balance Refeeding syndrome • The metabolic and physiologic consequences of the depletion, repletion, compartmental shifts and interrelationships of the followings – – – – – – Phosphorus (< 1mg/dl, death within hours) Potassium Magnesium Glucose metabolism Vitamin deficiency Fluid resuscitation Case History • 66 y/o female, abdominal pain and anorexia for 6 weeks • persistent profuse, yellow, watery diarrhea after construction an ileal conduit for ureteral obstruction lasting for 3 months • PE: BW 36 kg, 70% of IBW; afebrile, 108, 14, 98/70 anasarca, cachectic with generalized muscle wastage Hct 38%, WBC 17000, BUN/Cr 22/1.0, K 3.4, P 3.4, HCO3 17, Sugar 48, Alb. 1.59 • Hospital Course TPN was started with 750g dextrose, 120g AA, 60 mEq Na, 20 mEq K, 15 mmol P in 3L fluid 24 hrs after start of TPN, HR 180, SBP 50, CVP < 3 cmH2O P 0.7, Na 142, K 1.4, HCO3 19, Mg 1.8, Sugar 1010, BUN/Cr 27/1.3 pH 7.31, O2 59, CO2 24 (O2 2L) Apnea and respiratory failure developed within one hour With stopping TPN and fluid replacement, P 6.9, K 3.5 and Sugar 45 were obtained. In the following hospitalization, bilateral pneumonia and ARDS were complicated. Died on the 6th day • Autopsy: ischemic enterocolitis, pneumonia, ARDS and peritonitis and the heart was unremarkable Sequence of events Within 48 hrs of starting TPN P, Sugar, K, Meta. acidosis After correction of hypophosphatemia GI bleeding, Sepsis Tachycardia, Hypotension Persistent Cardiopulmonary Instability Apnea, MV support ARDS, Pneumonia Death Physiology of Starvation • When BMR = energy output to the limited intake, endogenous fuels must be used • Major storage fuel is fat in form of TG (60-75 days) • Carbohydrate, in contrast, is quantitatively insignificant storage fuel (1200 kcal, 1 day’s resting ER) • Protein, 12kg, 2 weeks’ worth of calories; but is for nonfuel function Metabolic Response to Refeeding • A shift from body fat to CHO as major fuel source • Insulin • Glycogenolysis, gluconeogenesis and FA mobilization from adipose tissue is inhibited • Cellular uptake of glucose, K, P, and Mg is enhanced by insulin • Antinatriuretic effect (Na retention and ECF expansion) Patient of risk for refeeding syndrome • • • • • • • • • Chronic alcoholism Anorexia nervosa Classic marasmus Classic kwashiorkor Chronic undernourishment Morbid obesity with massive weight loss Prolonged hypocaloric intravenous hydration NPO for greater than 7-10 days Cardiac and cancer cachexia Recommendations to avoid refeeding syndrome • Be aware of the syndrome • Recognize the patient at risk • Correct electrolyte imbalance before initiating nutritional support whether by the oral , enteral or parenteral route • Judiciously restore circulatory volume, monitor HR, and I/O • Increase caloric delivery slowly • Administer vitamins routinely • Closely monitor electrolyte over the 1st week: Serum P, K, Mg, Sugar and urine electrolytes • A little nutrition support is good, too much is lethal